Enclosed is our assessment of the Food and Drug Administration 's compliance with the procedural steps required by sections 801 ( a ) ( 1 ) ( B ) ( i ) through ( iv ) of title 5 with respect to the rule .
Our findings have found that the FDA 's sections 801 ( a ) ( 1 ) ( B ) ( i ) through ( iv ) of title 5 do not exist .